This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Prostate Disease  • Oncology  • Prostate Cancer  • Alert me on articles by topic

Peter H. Gann, MD, ScD; Misop Han, MD

JAMA. 2005;293:2149-2151.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Light from the stars in Stephan’s Quintet in the Pegasus constellation takes 270 million years to reach Earth. By the time this light arrives and allows observers to see these galaxies, the stars are no longer there. Observing the long-term outcomes for patients with minimally treated prostate cancer evokes a similar although much less extreme dilemma. In this issue of JAMA, Albertsen and colleagues¹ report updated results from a cohort of Connecticut men who received neither surgical nor radiation therapy for prostate cancer diagnosed between 1971 and 1984. This cohort is noteworthy because it is the largest of its kind yet assembled. In addition, it is population-based and has a mean follow-up time of more than 20 years—which is virtually Hubble telescope range given the pace of recent developments in prostate cancer detection.

It is vitally important to understand the outcomes . . . [Full Text of this Article]

Author Affiliations: Departments of Preventive Medicine (Dr Gann) and Urology (Dr Han), and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Ill.

RELATED ARTICLE

20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Peter C. Albertsen, James A. Hanley, and Judith Fine
JAMA. 2005;293(17):2095-2101.
ABSTRACT | FULL TEXT